De novo use of sirolimus in immunosuppression regimens in kidney and kidney-pancreas transplantation at the University of California, San Francisco

Transplantation Proceedings

Volumn 35, Issue 3 SUPPL., 2003, Pages S183-S186

  Vincenti, F ^a   Stock, P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; DACLIZUMAB; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ANEMIA; CLINICAL TRIAL; CONFERENCE PAPER; DIALYSIS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG TOLERANCE; DRUG USE; DRUG WITHDRAWAL; ETHNOLOGY; GRAFT FAILURE; HUMAN; HYPERLIPIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIPID DIET; MAINTENANCE THERAPY; PANCREAS TRANSPLANTATION; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT; SURGICAL PATIENT; SURGICAL WOUND; TREATMENT OUTCOME; UNITED STATES; UNIVERSITY;

EID: 0038298943     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(03)00237-9     Document Type: Conference Paper

References (5)

1. Vincenti F. Transplant Proc. 33:2001;3169.
2. Chang G.J., Adey D., Tomlanovich S., et al. J Am Soc Nephrol. 12:2002;882a.
3. Meier-Kriesche H.-U., Arndorfer J.A., Kaplan B. J Am Soc Nephrol. 13:2002;769.
4. McTaggart R.A., Gottlieb D., Brooks J.H., et al. Am J Transplant. 2:2002;276. [Abstract 550].
5. Shapiro A.M.J., Lakey J., Ryan E.A., et al. N Engl J Med. 343:2000;230.